Ipsen SA (IPSEY)
33.11
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Ipsen Price to Book Value: 2.590 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.590 |
| May 16, 2024 | 2.590 |
| May 15, 2024 | 2.569 |
| May 14, 2024 | 2.622 |
| May 13, 2024 | 2.521 |
| May 10, 2024 | 2.402 |
| May 09, 2024 | 2.402 |
| May 08, 2024 | 2.402 |
| May 07, 2024 | 2.365 |
| May 06, 2024 | 2.411 |
| May 03, 2024 | 2.410 |
| May 02, 2024 | 2.410 |
| May 01, 2024 | 2.352 |
| April 30, 2024 | 2.352 |
| April 29, 2024 | 2.352 |
| April 26, 2024 | 2.375 |
| April 25, 2024 | 2.360 |
| April 24, 2024 | 2.389 |
| April 23, 2024 | 2.331 |
| April 22, 2024 | 2.368 |
| April 19, 2024 | 2.250 |
| April 18, 2024 | 2.247 |
| April 17, 2024 | 2.239 |
| April 16, 2024 | 2.239 |
| April 15, 2024 | 2.283 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.283 |
| April 11, 2024 | 2.283 |
| April 10, 2024 | 2.332 |
| April 09, 2024 | 2.332 |
| April 08, 2024 | 2.328 |
| April 05, 2024 | 2.304 |
| April 04, 2024 | 2.323 |
| April 03, 2024 | 2.232 |
| April 02, 2024 | 2.242 |
| April 01, 2024 | 2.374 |
| March 31, 2024 | |
| March 28, 2024 | 2.338 |
| March 27, 2024 | 2.301 |
| March 26, 2024 | 2.331 |
| March 25, 2024 | 2.331 |
| March 22, 2024 | 2.322 |
| March 21, 2024 | 2.286 |
| March 20, 2024 | 2.211 |
| March 19, 2024 | 2.211 |
| March 18, 2024 | 2.261 |
| March 15, 2024 | 2.298 |
| March 14, 2024 | 2.298 |
| March 13, 2024 | 2.293 |
| March 12, 2024 | 2.281 |
| March 11, 2024 | 2.279 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.653
Minimum
Mar 19 2020
5.353
Maximum
Jun 27 2019
3.029
Average
2.841
Median
Oct 12 2023
Price to Book Value Benchmarks
| DBV Technologies SA | 1.092 |
| Cellectis SA | 2.532 |
| PHAXIAM Therapeutics SA (DELISTED) | 0.4731 |
| Genfit SA | 2.702 |
| Innate Pharma SA | 4.115 |
Price to Book Value Related Metrics
| Price | 33.11 |
| Market Cap | 10.95B |